Spoken Alpha
Beyond Air, Inc.
Beyond Air designs and operates a commercial-stage medical device and biopharmaceutical company developing nitric oxide (NO) generators and delivery systems for respiratory diseases and other conditions.
Beyond Air, Inc is a Healthcare company operating in Medical Devices with a $3.1M market cap.
Most recent reported earnings: Q2 FY2027 (Nov 8, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for XAIR.
$ curl https://api.spokenalpha.com/v1/companies/XAIRFAQ
Spoken Alpha indexes XAIR's earnings call transcripts at https://spokenalpha.com/companies/XAIR. Each call links to attributed speakers and parsed analyst Q&A. Beyond Air, Inc.'s own investor relations page is at https://www.beyondair.net/investors.
Beyond Air, Inc. (XAIR) held its most recent earnings call on 2025-11-10, covering fiscal Q2 2026.
Beyond Air, Inc. (XAIR) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 2026-11-08 | — | — | — | — | — | — | EODHD |
| Q1 FY2027 | 2026-08-12 | $11.00 | $-8.60 | +100.0% | $1.8M | — | — | EODHD |
| Q4 FY2026 | 2026-06-25 | $-0.77 | $-0.45 | -71.1% | $1.9M | — | — | EODHD |
| Q3 FY2026 | 2026-02-12 | $-0.85 | $-0.54 | -57.4% | $2.2M | — | — | EODHD |
| Q2 FY2026 | 2025-11-09 | $-1.25 | $-0.26 | -100.0% | $1.8M | — | — | EODHD |
| Q1 FY2026 | 2025-08-11 | $-1.53 | $-1.32 | -15.9% | $1.8M | — | — | EODHD |
| Q4 FY2025 | 2025-06-16 | $-0.09 | $-0.15 | +40.0% | $1.2M | — | — | EODHD |
| Q3 FY2025 | 2025-02-09 | $-3.00 | $-3.20 | +6.3% | $1.1M | — | — | EODHD |
| Q2 FY2025 | 2024-11-10 | $-5.60 | $-5.68 | +1.4% | $798.0K | — | — | EODHD |
| Q1 FY2025 | 2024-08-05 | $-5.40 | $-6.35 | +15.0% | $683.0K | — | — | EODHD |
| Q4 FY2024 | 2024-06-23 | $-0.36 | $-0.48 | +25.0% | $470.0K | — | — | EODHD |
| Q3 FY2024 | 2024-02-11 | $-10.00 | $-10.80 | +7.4% | $391.0K | — | — | EODHD |
| Q2 FY2024 | 2023-11-12 | $-10.20 | $-9.16 | -11.3% | $239.0K | — | — | EODHD |
| Q1 FY2024 | 2023-08-14 | $-9.00 | $-8.10 | -11.1% | $59.0K | — | — | EODHD |
| Q4 FY2023 | 2023-06-21 | $-0.67 | $-0.47 | -42.5% | $213.0K | — | — | EODHD |
| Q3 FY2023 | 2023-02-09 | $-8.60 | $-8.20 | -4.9% | $0 | — | — | EODHD |
| Q2 FY2023 | 2022-11-07 | $-8.00 | $-6.60 | -21.2% | $0 | — | — | EODHD |
| Q1 FY2023 | 2022-08-10 | $-7.40 | $-5.93 | -24.8% | $-213.0K | — | — | EODHD |
| Q4 FY2022 | 2022-06-27 | $-0.73 | $-0.27 | -100.0% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-02-09 | $-5.80 | $-5.20 | -11.5% | $0 | — | — | EODHD |
Source: EODHD. XAIR reported actuals as published; sparse fields render as —.